Fundz

Medicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Management

PUBLIC · MDNAFAug 14, 2023

Company

Medicenna

TorontoBiotechnologyHealth CareTherapeutics

Description

Brent Meadows, MBA, joins as Chief Business Officer , bringing over 25 years of large pharma and biotech experience and a track record of multiple high-value transactions in oncology and immuno-oncology. After over 6 years as CFO, Ms. Elizabeth Williams has chosen to pursue another biotech opportunity. A search for her replacement is currently underway. Company strengthens the management team with the appointment of Delphine Davan, MSc, MBA, as VP of Investor Relations, Evelyn Pau, PhD, as VP of External Collaborations; promotion of Eamonn Peters, CPA, CA to VP of Finance and Minh To, PhD, as VP of Oncology Research. TORONTO and HOUSTON, Aug

Quick answer

Medicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Management (August 14, 2023). Medicenna is based in Toronto, Ontario, Canada.

What did Medicenna announce on August 14, 2023?
Brent Meadows, MBA, joins as Chief Business Officer , bringing over 25 years of large pharma and biotech experience and a track record of multiple high-value transactions in oncology and immuno-oncology. After over 6 years as CFO, Ms. Elizabeth Williams has chosen to pursue another biotech opportunity.
What does Medicenna do?
Medicenna is a clinical stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Superkines.
Where is Medicenna based?
Medicenna is based in Toronto, Ontario, Canada.
Which similar companies made leadership changes around the same time?
AbSci Corp (August 14, 2023), HALO Precision Diagnostics (August 16, 2023), Apex Labs (August 10, 2023) and Arcutis (August 18, 2023) also announced leadership changes within 45 days of Medicenna.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Medicenna, and when

A new leader at Medicenna brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Medicenna raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Medicenna, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Medicenna. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Medicenna

Location

Toronto, Ontario, Canada

About

Medicenna is a clinical stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Superkines. Medicenna's long-acting IL-2 Superkine, MDNA11, is a next-generation IL-2 with superior CD122 binding without CD25 affinity thereby preferentially stimulating cancer killing effector T cells and NK cells. Medicenna’s early-stage BiSKITs™ program, (Bifunctional SuperKine ImmunoTherapies) is designed to enhance the ability of Superkines to treat immunologically “cold” tumors. Medicenna's IL-4 Empowered Superkine, MDNA55, has been studied in 5 clinical trials including a Phase 2b trial for recurrent GBM, the most common and uniformly fatal form of brain cancer. MDNA55 has obtained Fast-Track and Orphan Drug status from the FDA and FDA/EMA, respectively.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Medicenna changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Humphrey
Likely contact at this company
••••••••@••••••••

See Humphrey's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Medicenna's next move

Learn about Strategic plan

Medicenna changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.